MedTrace Logo

ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)

NCT06900296 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-10-16

No results posted yet for this study

Summary

This is a prospective observational study that will collect blood samples at 1-10 timepoints related to initiation of immunotherapy. The study may collect samples before the start of immunotherapy and/or at clinically significant timepoints during immunotherapy treatment.

Conditions

Sponsors & Collaborators

  • Indiana Institute of Personalized Medicine

    collaborator UNKNOWN

  • Indiana University

    lead OTHER

Principal Investigators

  • Tyler Shugg, PharmD, PhD · Indiana University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2029-04-30
Completion
2029-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06900296 on ClinicalTrials.gov